First published 9/30/2026, 8:00:15 AM · Last updated 9/30/2026, 8:00:15 AM

Geschlechtsspezifische Limitationen der körperoberflächenbasierten Chemotherapiedosierung bei Patienten mit Adenokarzinomen des Magens und gastroösophagealen Überganges

Journal article (Georg Thieme Verlag KG) published 2026-08-01 reporting on sex-specific limitations of body-surface-area–based chemotherapy dosing in patients with gastric and gastroesophageal junction adenocarcinomas. No additional study details or results were included in the supplied source data.

Categories: public-health, science-and-space

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 2/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 2/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 2/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The article addresses potential sex-related limitations in chemotherapy dosing for these cancer patients.

Sources

Geschlechtsspezifische Limitationen der körperoberflächenbasierten Chemotherapiedosierung bei Patienten mit Adenokarzinomen des Magens und gastroösophagealen Überganges

Report an issue